$CYTK CYTOKINETICS INC Insiders

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in CYTOKINETICS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of current and past insiders in CYTOKINETICS INC. Find out how many shares they currently own, their value and whether they buy or sell their shares.

CYTOKINETICS INC Insiders

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
BARBARI SHARON SURREYEVP, Finance & CFO47,640557,388shares bought: 18,750 / shares sold: -7,317 BUYMar 02 2017
BARBARI SHARON SURREYEVP, Finance & CFO24,778289,903Feb 26 2014
Bhanji MunaDirector5,00058,500shares bought: 5,000 / shares sold: 0 BUYMay 13 202115 months ago
Blum Robert IPresident & CEO361,8594,233,750shares bought: 782,521 / shares sold: -457,526 STRONG BUYMay 07 202115 months ago
Blum Robert IPresident & CEO3,27638,329Feb 26 2014
BVF PARTNERS L P/IL10% Owner3,811,27144,591,871shares bought: 342,072 / shares sold: -1,502,984 STRONG SELLDec 11 202020 months ago
Califf RobertDirector5,45963,870shares bought: 5,204 / shares sold: 0 STRONG BUYMay 13 202115 months ago
Callos AndrewEVP, Chief Commercial Officers00Apr 05 202117 months ago
CHARPENTIER BONNIESVP Regulatory & Compliance15,000175,500shares bought: 35,000 / shares sold: -5,996 STRONG BUYMar 02 2017
CHARPENTIER BONNIESVP Regulatory & Compliance00Feb 03 2014
COSTA SANTO JDirector5,00058,500shares bought: 88,331 / shares sold: -83,331 BUYMay 13 202115 months ago
COSTA SANTO JDirector00May 22 2014
Cragg DavidSVP Human Resources160,6251,879,313shares bought: 151,666 / shares sold: -40,631 STRONG BUYMar 09 202117 months ago
CREDIT SUISSE FIRST BOSTON/10% Owner1,765,68320,658,491May 05 2004
DOW STEPHEN MDirector60,000702,000Oct 29 2004
DOW STEPHEN MDirector3,164,00337,018,835Apr 29 2004
DOW STEPHEN MDirector1,421,05216,626,308Jan 04 2013
Eastern Capital LTD10% Owner2,883,84533,740,987Feb 27 2014
GAGE L PATRICKDirector27,529322,089shares bought: 52,155 / shares sold: -53,584 SELLMay 13 202115 months ago
GAGE L PATRICKDirector8509,945May 22 2014
GILBERT DENISEDirector00May 21 2015
GILBERT DENISEDirector00May 22 2014
HEIDRICH A GRANT IIIDirector93,7551,096,934Jan 05 2011
HENDERSON JOHN TDirector12,410145,197shares bought: 15,524 / shares sold: -9,875 BUYMay 13 202115 months ago
HENDERSON JOHN TDirector00Jan 05 2015
HOMCY CHARLES JDirector00May 27 2008
JAGGERS JOHN V10% Owner3,164,00337,018,835Apr 29 2004
Jaw ChingSVP Finance & CFO88,4921,035,356shares bought: 127,500 / shares sold: -63,816 STRONG BUYMar 09 202117 months ago
Kaye Edward M. MDDirector5,92069,264shares bought: 25,409 / shares sold: -20,000 BUYMay 13 202115 months ago
Malik Fady IbrahamEVP Research & Development160,3481,876,072shares bought: 261,666 / shares sold: -112,583 STRONG BUYMay 13 202115 months ago
MAYFIELD IX10% Owner13,705160,349May 04 2004
MCDADE MARKDirector00May 22 2009
McDowell Caryn GordonGC & Chief Compliance Officer35,000409,500shares bought: 70,416 / shares sold: -44,181 BUYMar 01 2018
Morgan Bradley PaulSVP Drug Discovery & Early Dev63,107738,352shares bought: 153,330 / shares sold: -124,316 BUYSep 01 2017
MORGANS DAVID J JREVP-Preclinical R&D42,000491,400Mar 01 2011
PARSHALL B LYNNEDirector5,00058,500shares bought: 71,821 / shares sold: -66,821 BUYMay 13 202115 months ago
PARSHALL B LYNNEDirector00Jan 05 2015
RABSON MICHAELSVP Business Dev/Legal & GC20,043234,503Dec 21 2009
RODDY PETER SSVP Finance & CAO21,520251,784shares bought: 20,000 / shares sold: 0 BUYMar 01 2018
RUTTER WILLIAM JDirector172,4132,017,232May 03 2004
Sabry James HDirector00Jun 04 2010
SCHLOSSBERG MARK ASVP - Legal & General Counsel50,850594,945shares bought: 75,000 / shares sold: -24,150 STRONG BUYMar 09 202117 months ago
SCHMERTZLER MICHAELDirector3,105,26136,331,554May 23 2005
SCHMERTZLER MICHAELDirector00Jan 06 2009
SCHMERTZLER MICHAELDirector5,389,20863,053,734May 22 2009
SCHMERTZLER MICHAELDirector4,340,92350,788,799Jun 04 2010
Schnieders ElisabethSr. VP, Business Development28,985339,125shares bought: 32,500 / shares sold: -5,066 STRONG BUYMar 02 2017
SEVIN ROSEN FUND VI LP10% Owner1,615,71618,903,877Apr 29 2004
SEVIN ROSEN FUND VII LP10% Owner625,9507,323,615Apr 29 2004
SEVIN ROSEN FUND VIII LP10% Owner755,6318,840,883Apr 29 2004
SEVIN ROSEN VI AFFILIATES FUND LP10% Owner127,2351,488,650Apr 29 2004
SEVIN ROSEN VII AFFILIATES FUND LP10% Owner24,050281,385Apr 29 2004
SEVIN ROSEN VIII AFFILIATES FUND LP10% Owner15,421180,426Apr 29 2004
SMITH SANDFORD DDirector5,92069,264shares bought: 184,922 / shares sold: -179,513 BUYMay 13 202115 months ago
SMITH SANDFORD DDirector00Jan 05 2015
SPUDICH JAMES ADirector180,6002,113,020May 19 2011
SRB ASSOCIATES VI LP10% Owner1,742,95120,392,527Apr 29 2004
SRB ASSOCIATES VII LP10% Owner650,0007,605,000Apr 29 2004
SRB ASSOCIATES VIII LP10% Owner771,0529,021,308Apr 29 2004
TRAUTMAN JAY KVP, Discovery Research47,896560,383Mar 04 2008
WIERENGA WENDALLDirector00Jan 05 2015
WIERENGA WENDALL DDirector5,92069,264shares bought: 15,408 / shares sold: -9,999 BUYMay 13 202115 months ago
WOLFF ANDREW ASVP & CMO37,239435,696shares bought: 27,500 / shares sold: -4,984 STRONG BUYMar 02 2017
WOLFF ANDREW ASVP Clinical R&D, CMO20,637241,453Sep 05 2013
Wong RobertVP, Chief Accounting Officer23,879279,384shares bought: 20,000 / shares sold: -1,359 STRONG BUYMar 09 202117 months ago
Wysenski NancyDirector5,45963,870shares bought: 5,204 / shares sold: 0 STRONG BUYMay 13 202115 months ago